Sofosbuvir and Velpatasvir Regimen Outcome for Chronic Hepatitis C Patients With End-Stage Renal Disease Undergoing Hemodialysis

Background Patients on hemodialysis (HD) are most likely to contract hepatitis C (HCV) infection, which is associated with significant morbidity and disease progression. Direct-acting antivirals (DAAs) are safe and tolerable in chronic kidney disease (CKD) with a 90-100% cure rate, and limited data...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahid, Salman, Asghar, Shoaib, Mahmood, Tayyab, Fatima, Mishal, Rasheed, Ali, Asghar, Sohaib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590019/
https://www.ncbi.nlm.nih.gov/pubmed/37868481
http://dx.doi.org/10.7759/cureus.45680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590019/
https://www.ncbi.nlm.nih.gov/pubmed/37868481
http://dx.doi.org/10.7759/cureus.45680

Ejemplares similares